Figure 1
Figure 1. DNA CNAs in 300 newly diagnosed adult and pediatric patients with CBF-AML. (A) Log2 ratio SNP copy number data of diagnostic leukemia cells (median-smoothed with a window of 5 markers; blue indicates deletion and red gain). Each column represents a case, and the SNPs are arranged in rows according to chromosomal location. Cases are arranged by subgroup. Gross changes can be observed for example in chromosome 8 (17 cases with trisomy 8). (B) Analysis via GISTIC of copy number losses (left) and gains (right). False-discovery rate q values are plotted along the x-axis with chromosomal position along the y-axis. Altered regions with significance levels exceeding 0.25 (marked by vertical green line) were deemed significant. Nine significant regions of deletion, and 2 significant regions of amplification were identified. Chromosomal positions are shown for each significant region on the right side of the plots.

DNA CNAs in 300 newly diagnosed adult and pediatric patients with CBF-AML. (A) Log2 ratio SNP copy number data of diagnostic leukemia cells (median-smoothed with a window of 5 markers; blue indicates deletion and red gain). Each column represents a case, and the SNPs are arranged in rows according to chromosomal location. Cases are arranged by subgroup. Gross changes can be observed for example in chromosome 8 (17 cases with trisomy 8). (B) Analysis via GISTIC of copy number losses (left) and gains (right). False-discovery rate q values are plotted along the x-axis with chromosomal position along the y-axis. Altered regions with significance levels exceeding 0.25 (marked by vertical green line) were deemed significant. Nine significant regions of deletion, and 2 significant regions of amplification were identified. Chromosomal positions are shown for each significant region on the right side of the plots.

Close Modal

or Create an Account

Close Modal
Close Modal